Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02774850 · ClinicalTrials.gov registry record
Home Away From Home - Medical Outcomes
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 610
- Enrollment target
NCT02774850 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 610 participants.
The verdict
NCT02774850 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 610 participants
- Enrollment target
Study Summary
Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patients, but there are little clinical data to inform whether management of neutropenia post AML chemotherapy should occur in an outpatient or inpatient setting. The primary objective of this study is to compare the clinical effectiveness of outpatient versus inpatient management of neutropenia in children with AML.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-07-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02774850
The ClinicalTrials.gov registry entry for NCT02774850 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02774850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02774850 about?
NCT02774850 is a clinical study titled "Home Away From Home - Medical Outcomes". Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patien...
What is the current status of trial NCT02774850?
This trial is currently completed. The enrollment target is 610 participants. The study started on 2015-06. Estimated completion is 2019-07-26.
Who is sponsoring clinical trial NCT02774850?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.